TearCare Dry Eye Treatment in San Francisco
TearCare dry eye treatment in San Francisco is designed for patients whose symptoms are linked to meibomian gland dysfunction (MGD), one of the most common causes of evaporative dry eye disease. When the oil-producing glands along the eyelids become blocked or underperform, tears can evaporate too quickly, causing dryness, burning, irritation, redness, watery eyes, fluctuating vision, and blurry vision.
At Mosaddegh Eye Institute, Dr. Lillie Mosaddegh and the care team evaluate the eyelids, tear film, and ocular surface before recommending treatment. This helps determine whether TearCare®, manual gland expression, IPL, LipiFlow, OptiLIGHT, BlephEx, or another dry eye therapy is the right fit for your symptoms and gland health.
How TearCare® Treats Meibomian Gland Dysfunction
TearCare® is an FDA-cleared in-office dry eye treatment that applies controlled therapeutic heat to the eyelids while allowing patients to blink naturally. This targeted heat helps soften thickened meibum inside blocked meibomian glands. After heating, the glands are gently expressed to help restore healthier oil flow.
By improving the oil layer of the tear film, TearCare for MGD may help reduce rapid tear evaporation, improve tear film stability, support ocular surface health, and relieve chronic dry eye symptoms for appropriate candidates.
When TearCare and Manual Gland Expression May Be Recommended
Many patients with meibomian gland dysfunction benefit from a combination approach. TearCare treatment warms and softens blocked oils, while manual meibomian gland expression helps clear the softened oils from the glands. This combination can be especially helpful when at-home warm compresses, artificial tears, or lid hygiene are not enough.
Our team performs a detailed dry eye evaluation to determine whether TearCare in San Francisco should be used alone or paired with other in-office dry eye therapies based on gland blockage, inflammation, symptoms, and tear film quality.
Benefits of TearCare for Dry Eye
- Targets the root cause of evaporative dry eye related to MGD
- Restores meibomian gland function by helping clear blocked oils
- Improves tear film quality and stability to reduce evaporation
- Helps relieve chronic dry eye symptoms such as burning, irritation, redness, and fluctuating vision
- Comfortable, non-invasive in-office treatment with minimal downtime
- Can be combined with manual gland expression and other dry eye therapies when clinically appropriate
Is TearCare Right for You?
TearCare may be an effective treatment option for patients with chronic dry eye symptoms related to MGD, especially when standard drops, artificial tears, warm compresses, or eyelid hygiene have not provided enough relief. It may also be considered for patients with blocked glands, unstable tear film, evaporative dry eye, or recurring symptoms that return after temporary improvement.
A comprehensive evaluation at Mosaddegh Eye Institute is needed to confirm whether TearCare San Francisco dry eye treatment is appropriate for your eyes.
What to Expect During TearCare Treatment
Treatment time: TearCare typically takes about 12–15 minutes, followed by gland expression when appropriate.
Sensation: Most patients feel gentle warmth along the eyelids. Mild pressure may be felt during meibomian gland expression.
Downtime: Most patients can return to normal daily activities soon after treatment.
Results: Improvement may develop over days to weeks as gland function and tear film quality improve.
Maintenance: Some patients benefit from repeat TearCare dry eye treatments depending on the severity of MGD and symptom recurrence.
Frequently Asked Questions
TearCare treats evaporative dry eye disease caused by meibomian gland dysfunction (MGD). It helps warm and clear blocked oil glands so the tear film can become more stable and less likely to evaporate quickly.
TearCare dry eye treatment applies controlled heat to the eyelids while allowing natural blinking. After the oils soften, the glands may be expressed to improve oil flow, reduce evaporation, and relieve symptoms such as burning, irritation, redness, watery eyes, and fluctuating vision.
Yes. TearCare is FDA-cleared and performed in-office by an eye care professional. A dry eye evaluation is completed first to confirm whether the treatment is appropriate for your eyelids, tear film, and ocular surface.
Some patients notice improvement within days to weeks, while others improve gradually as meibomian gland function and tear film stability improve. Results vary based on the severity of MGD and whether additional treatments are needed.
Results vary by patient. Many patients experience lasting relief, but maintenance TearCare treatments may be recommended when gland blockage or dry eye symptoms return.
Find Out If TearCare® Is Right for Your Dry Eye
Schedule a dry eye evaluation at Mosaddegh Eye Institute to learn whether TearCare San Francisco dry eye treatment can help improve your comfort, tear film stability, and meibomian gland function.
